Ken Fisher's KNSA Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 323,808 shares of Kiniksa Pharmaceuticals International, plc (KNSA) worth $24.16 M, representing 0.01% of the portfolio. First purchased in 2024-Q2, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Ken Fisher has maintained a strategic position in KNSA, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 180,029 shares. Largest reduction occurred in Q3 2026, reducing 74,458 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Kiniksa Pharmaceuticals International plc (KNSA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Kiniksa Pharmaceuticals International plc (KNSA) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | -74,458 | Reduce 18.70% | 323,808 | $74.61 |
| Q2 2026 | -30,706 | Reduce 7.16% | 398,266 | $63.95 |
| Q1 2026 | +161,698 | Add 60.50% | 428,972 | $48.15 |
| Q4 2025 | -15,014 | Reduce 5.32% | 267,274 | $41.25 |
| Q3 2025 | +180,029 | Add 176.05% | 282,288 | $38.83 |
| Q2 2025 | -41,992 | Reduce 29.11% | 102,259 | $27.67 |
| Q1 2025 | +118,127 | Add 452.18% | 144,251 | $22.21 |
| Q3 2024 | -4,101 | Reduce 13.57% | 26,124 | $24.99 |
| Q2 2024 | +30,225 | New Buy | 30,225 | $18.67 |
Ken Fisher's Kiniksa Pharmaceuticals International plc Investment FAQs
Ken Fisher first purchased Kiniksa Pharmaceuticals International, plc (KNSA) in Q2 2024, acquiring 30,225 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Kiniksa Pharmaceuticals International, plc (KNSA) for 10 quarters since Q2 2024.
Ken Fisher's largest addition to Kiniksa Pharmaceuticals International, plc (KNSA) was in Q3 2025, adding 282,288 shares worth $10.96 M.
According to the latest 13F filing for Q3 2026, Ken Fisher's firm, Fisher Asset Management, LLC, owns 323,808 shares of Kiniksa Pharmaceuticals International, plc (KNSA), valued at approximately $24.16 M.
As of the Q3 2026 filing, Kiniksa Pharmaceuticals International, plc (KNSA) represents approximately 0.01% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in Kiniksa Pharmaceuticals International, plc (KNSA) was 428,972 shares, as reported at the end of Q1 2026.